DOCSLIB.ORG

Mirnas in Control of Oncogenic Signaling in Breast Cancer Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mirnas in Control of Oncogenic Signaling in Breast Cancer Cells miRNAs in control of oncogenic signaling in breast cancer cells Von der Fakultät Energie-, Verfahrens- und Biotechnik der Universität Stuttgart zur Erlangung der Würde eines Doktors der Naturwissen- schaften (Dr. rer. nat.) genehmigte Abhandlung Vorgelegt von Annabell Bischoff aus Segnitz Hauptberichter: Prof. Dr. Monilola Olayioye Mitberichter: Prof. Dr. Klaus Pfizenmaier Tag der mündlichen Prüfung: 12.11.2014 Institut für Zellbiologie und Immunologie Universität Stuttgart 2014 2 2 3 Eidesstattliche Erklärung Hiermit erkläre ich, Annabell Bischoff, dass ich die vorliegende Arbeit selbständig angefertigt habe. Es wurden nur die in der Arbeit ausdrücklich benannten Quellen und Hilfsmittel be- nutzt. Wörtlich oder sinngemäß übernommenes Gedankengut habe ich als solches kenntlich gemacht. I hereby assure that I performed this work independently without further help or other materi- als than stated. ______________________ ______________________ Datum, Ort Unterschrift 3 4 4 5 Table of content Eidesstattliche Erklärung ....................................................................................................... 3 Table of content ..................................................................................................................... 5 Abbreviations ........................................................................................................................ 9 Abstract ................................................................................................................................13 Zusammenfassung ...............................................................................................................15 1 Introduction ...................................................................................................................17 1.1 Breast Cancer ........................................................................................................17 1.2 Development of breast cancer ................................................................................17 1.3 ErbB receptors .......................................................................................................18 1.4 ErbB2-ErbB3 receptor dimer ..................................................................................20 1.5 PI3K/Akt signaling ..................................................................................................22 1.6 Ras-ERK (Extracellular Signal Regulated Kinase) and PLCγ signaling ..................25 1.7 Cell motility .............................................................................................................26 1.8 miRNAs ..................................................................................................................27 1.8.1 miRNA biogenesis ...........................................................................................27 1.8.2 miRNA targeting ..............................................................................................28 1.8.3 Nomenclature of miRNAs ................................................................................29 1.8.4 miRNA target prediction ..................................................................................30 1.8.5 miRNAs and their biological function ...............................................................31 1.8.6 miRNAs in cancer ...........................................................................................31 1.8.7 Aim of the thesis ..............................................................................................33 2 Materials and Methods ..................................................................................................35 2.1 Materials ................................................................................................................35 2.1.1 Equipment .......................................................................................................35 2.1.2 Chemicals and consumables ...........................................................................36 2.1.3 Buffers and solutions .......................................................................................37 2.1.4 Bacterial strain ................................................................................................38 2.1.5 Cell lines, cell culture medium .........................................................................38 2.1.6 Animals ...........................................................................................................39 2.1.7 Oligonucleotides ..............................................................................................39 2.1.8 Kits and enzymes ............................................................................................42 5 6 2.2 Methods .................................................................................................................42 2.2.1 Cell culture ......................................................................................................42 2.2.2 Cell transfection ..............................................................................................43 2.2.3 Screening workflow .........................................................................................43 2.2.4 In-Cell Western analysis (ICW) .......................................................................43 2.2.5 Plasmid Constructs – QuickChange Site directed PCR Mutagenesis ..............44 2.2.6 Transformation of E.coli ..................................................................................44 2.2.7 Purification of plasmid DNA (Mini-Prep) ..........................................................45 2.2.8 Preparation of plasmid DNA (Midi-Prep) ..........................................................45 2.2.9 Migration/Invasion (Transwell) Assay ..............................................................45 2.2.10 Impedance measurement ................................................................................45 2.2.11 Proliferation Assay ..........................................................................................46 2.2.12 Life cell imaging ..............................................................................................46 2.2.13 Luciferase Reporter Assay ..............................................................................46 2.2.14 Rac activity assay. ..........................................................................................46 2.2.15 Quantitative Real Time PCR ...........................................................................46 2.2.16 Cell lysis, SDS-PAGE and Western Blotting ....................................................47 2.2.17 FACS analysis .................................................................................................47 2.2.18 Immunofluorescence microscopy ....................................................................48 2.2.19 Animal experiment ..........................................................................................48 2.2.20 Target prediction analysis for miR-149 using KEGG........................................48 3 Results ..........................................................................................................................49 3.1 miRNA Screen .......................................................................................................49 3.1.1 Establishment of a screening procedure to monitor Akt activation upon HRG stimulation .....................................................................................................................49 3.1.2 miR-149 serves as a positive control for the screen targeting the ErbB3 3’UTR 51 3.1.3 Genome-wide miRNA screening for regulators of HRG-induced Akt activation 54 3.1.4 Identification of a miRNA-ErbB interaction network. ........................................58 3.1.5 Expression of miR-148b, miR-149, miR-326 and miR-520a-3p reduces ErbB3- expression and affects Erk and Akt signaling ................................................................61 3.1.6 Overexpression of miR-148b, miR-149, miR-326 and miR-520a-3p reduces the heregulin-driven proliferation. ........................................................................................63 3.2 miR-149 in breast cancer .......................................................................................65 6 7 3.2.1 Clinical data of miR-149 ..................................................................................65 3.2.3 miR-149 expression affects cell adhesion and cell spreading ..........................67 3.2.5 miR-149 expression affects Rac activity ..........................................................71 3.2.6 miR-149 affects migration and invasion also in the prostate cancer cell line PC3 73 3.2.7 miR-149 expression in vivo model ...................................................................74 4 Discussion .....................................................................................................................77 4.1 miRNA Screen .......................................................................................................77 4.1.1 Screening for miRNAs altering the ErbB/Akt pathway .....................................77 4.1.2 miRNAs alter heregulin-dependent Akt activation ............................................78 4.1.3 Protein target network of miRNAs negatively affecting ΔpAkt ..........................79 4.1.4 Protein target network of miRNAs enhancing ΔpAkt ........................................82 4.1.5 miRNAs regulate
Load more

Recommended publications
  • 1 Early Patterning and Specification of Cardiac Progenitors In
    Early Patterning and Specification of Cardiac Progenitors in Gastrulating Mesoderm W. Patrick Devine1,2,3,4, Joshua D. Wythe1,2, Matthew George1,2,5 , Kazuko Koshiba- Takeuchi1,2, Benoit G. Bruneau1,2,4,5 1. Gladstone Institute of Cardiovascular Disease, San Francisco, CA, 94158 USA 2. Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA 3. Department of Pathology, University of California, San Francisco, CA 94143 USA 4. Cardiovascular Research Institute, University of California, San Francisco, CA 94158 USA 5. Developmental and Stem Cell Biology Program, University of San Francisco, CA 94143, USA 6. Department of Pediatrics, University of California, San Francisco, CA 94143 USA Competing interests statement: The authors declare no competing interests. 1 Abstract Mammalian heart development requires precise allocation of cardiac progenitors. The existence of a multipotent progenitor for all anatomic and cellular components of the heart has been predicted but its identity and contribution to the two cardiac progenitor "fields" has remained undefined. Here we show, using clonal genetic fate mapping, that Mesp1+ cells in gastrulating mesoderm are rapidly specified into committed cardiac precursors fated for distinct anatomic regions of the heart. We identify Smarcd3 as a marker of early specified cardiac precursors and identify within these precursors a compartment boundary at the future junction of the left and right ventricles that arises prior to morphogenesis. Our studies define the timing and hierarchy of cardiac progenitor specification and demonstrate that the cellular and anatomical fate of mesoderm-derived cardiac cells is specified very early. These findings will be important to understand the basis of congenital heart defects and to derive cardiac regeneration strategies.
    [Show full text]
  • Co-Occupancy by Multiple Cardiac Transcription Factors Identifies
    Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart Aibin Hea,b,1, Sek Won Konga,b,c,1, Qing Maa,b, and William T. Pua,b,2 aDepartment of Cardiology and cChildren’s Hospital Informatics Program, Children’s Hospital Boston, Boston, MA 02115; and bHarvard Stem Cell Institute, Harvard University, Cambridge, MA 02138 Edited by Eric N. Olson, University of Texas Southwestern, Dallas, TX, and approved February 23, 2011 (received for review November 12, 2010) Identification of genomic regions that control tissue-specific gene study of a handful of model genes (e.g., refs. 7–10), it has not been expression is currently problematic. ChIP and high-throughput se- evaluated using unbiased, genome-wide approaches. quencing (ChIP-seq) of enhancer-associated proteins such as p300 In this study, we used a modified ChIP-seq approach to define identifies some but not all enhancers active in a tissue. Here we genome wide the binding sites of these cardiac TFs (1). We show that co-occupancy of a chromatin region by multiple tran- provide unbiased support for collaborative TF interactions in scription factors (TFs) identifies a distinct set of enhancers. GATA- driving cardiac gene expression and use this principle to show that chromatin co-occupancy by multiple TFs identifies enhancers binding protein 4 (GATA4), NK2 transcription factor-related, lo- with cardiac activity in vivo. The majority of these multiple TF- cus 5 (NKX2-5), T-box 5 (TBX5), serum response factor (SRF), and “ binding loci (MTL) enhancers were distinct from p300-bound myocyte-enhancer factor 2A (MEF2A), here referred to as cardiac enhancers in location and functional properties.
    [Show full text]
  • Supraphysiological Levels of Oxygen Exposure During the Neonatal
    www.nature.com/scientificreports OPEN Supraphysiological Levels of Oxygen Exposure During the Neonatal Period Impairs Signaling Received: 15 January 2018 Accepted: 4 June 2018 Pathways Required for Learning Published: xx xx xxxx and Memory Manimaran Ramani1, Ranjit Kumar2, Brian Halloran1, Charitharth Vivek Lal1, Namasivayam Ambalavanan 1,3 & Lori L. McMahon3,4 Preterm infants often require prolonged oxygen supplementation and are at high risk of neurodevelopmental impairment. We recently reported that adult mice exposed to neonatal hyperoxia (postnatal day [P] 2 to 14) had spatial navigation memory defcits associated with hippocampal shrinkage. The mechanisms by which early oxidative stress impair neurodevelopment are not known. Our objective was to identify early hyperoxia-induced alterations in hippocampal receptors and signaling pathways necessary for memory formation. We evaluated C57BL/6 mouse pups at P14, exposed to either 85% oxygen or air from P2 to 14. We performed targeted analysis of hippocampal ligand-gated ion channels and proteins necessary for memory formation, and global bioinformatic analysis of diferentially expressed hippocampal genes and proteins. Hyperoxia decreased hippocampal mGLU7, TrkB, AKT, ERK2, mTORC1, RPS6, and EIF4E and increased α3, α5, and ɤ2 subunits of GABAA receptor and PTEN proteins, although changes in gene expression were not always concordant. Bioinformatic analysis indicated dysfunction in mitochondria and global protein synthesis and translational processes. In conclusion, supraphysiological oxygen exposure reduced proteins necessary for hippocampus-dependent memory formation and may adversely impact hippocampal mitochondrial function and global protein synthesis. These early hippocampal changes may account for memory defcits seen in preterm survivors following prolonged oxygen supplementation. Children born preterm with a relatively uncomplicated neonatal intensive care unit course ofen have defcits in executive function and learning and memory1–3.
    [Show full text]
  • The Use of Phosphoproteomic Data to Identify Altered Kinases and Signaling Pathways in Cancer
    The use of phosphoproteomic data to identify altered kinases and signaling pathways in cancer By Sara Renee Savage Thesis Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE in Biomedical Informatics August 10, 2018 Nashville, Tennessee Approved: Bing Zhang, Ph.D. Carlos Lopez, Ph.D. Qi Liu, Ph.D. ACKNOWLEDGEMENTS The work presented in this thesis would not have been possible without the funding provided by the NLM training grant (T15-LM007450) and the support of the Biomedical Informatics department at Vanderbilt. I am particularly indebted to Rischelle Jenkins, who helped me solve all administrative issues. Furthermore, this work is the result of a collaboration between all members of the Zhang lab and the larger CPTAC consortium. I would like to thank the other CPTAC centers for processing the data, and Chen Huang and Suhas Vasaikar in the Zhang lab for analyzing the colon cancer copy number and proteomic data, respectively. All members of the Zhang lab have been extremely helpful in answering any questions I had and offering suggestions on my work. Finally, I would like to acknowledge my mentor, Bing Zhang. I am extremely grateful for his guidance and for giving me the opportunity to work on these projects. ii TABLE OF CONTENTS Page ACKNOWLEDGEMENTS ................................................................................................ ii LIST OF TABLES............................................................................................................
    [Show full text]
  • Supplementary Figure 1. Network Map Associated with Upregulated Canonical Pathways Shows Interferon Alpha As a Key Regulator
    Supplementary Figure 1. Network map associated with upregulated canonical pathways shows interferon alpha as a key regulator. IPA core analysis determined interferon-alpha as an upstream regulator in the significantly upregulated genes from RNAseq data from nasopharyngeal swabs of COVID-19 patients (GSE152075). Network map was generated in IPA, overlaid with the Coronavirus Replication Pathway. Supplementary Figure 2. Network map associated with Cell Cycle, Cellular Assembly and Organization, DNA Replication, Recombination, and Repair shows relationships among significant canonical pathways. Significant pathways were identified from pathway analysis of RNAseq from PBMCs of COVID-19 patients. Coronavirus Pathogenesis Pathway was also overlaid on the network map. The orange and blue colors in indicate predicted activation or predicted inhibition, respectively. Supplementary Figure 3. Significant biological processes affected in brochoalveolar lung fluid of severe COVID-19 patients. Network map was generated by IPA core analysis of differentially expressed genes for severe vs mild COVID-19 patients in bronchoalveolar lung fluid (BALF) from scRNA-seq profile of GSE145926. Orange color represents predicted activation. Red boxes highlight important cytokines involved. Supplementary Figure 4. 10X Genomics Human Immunology Panel filtered differentially expressed genes in each immune subset (NK cells, T cells, B cells, and Macrophages) of severe versus mild COVID-19 patients. Three genes (HLA-DQA2, IFIT1, and MX1) were found significantly and consistently differentially expressed. Gene expression is shown per the disease severity (mild, severe, recovered) is shown on the top row and expression across immune cell subsets are shown on the bottom row. Supplementary Figure 5. Network map shows interactions between differentially expressed genes in severe versus mild COVID-19 patients.
    [Show full text]
  • Downregulation of Carnitine Acyl-Carnitine Translocase by Mirnas
    Page 1 of 288 Diabetes 1 Downregulation of Carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion Mufaddal S. Soni1, Mary E. Rabaglia1, Sushant Bhatnagar1, Jin Shang2, Olga Ilkayeva3, Randall Mynatt4, Yun-Ping Zhou2, Eric E. Schadt6, Nancy A.Thornberry2, Deborah M. Muoio5, Mark P. Keller1 and Alan D. Attie1 From the 1Department of Biochemistry, University of Wisconsin, Madison, Wisconsin; 2Department of Metabolic Disorders-Diabetes, Merck Research Laboratories, Rahway, New Jersey; 3Sarah W. Stedman Nutrition and Metabolism Center, Duke Institute of Molecular Physiology, 5Departments of Medicine and Pharmacology and Cancer Biology, Durham, North Carolina. 4Pennington Biomedical Research Center, Louisiana State University system, Baton Rouge, Louisiana; 6Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, New York. Corresponding author Alan D. Attie, 543A Biochemistry Addition, 433 Babcock Drive, Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, (608) 262-1372 (Ph), (608) 263-9608 (fax), [email protected]. Running Title: Fatty acyl-carnitines enhance insulin secretion Abstract word count: 163 Main text Word count: 3960 Number of tables: 0 Number of figures: 5 Diabetes Publish Ahead of Print, published online June 26, 2014 Diabetes Page 2 of 288 2 ABSTRACT We previously demonstrated that micro-RNAs 132 and 212 are differentially upregulated in response to obesity in two mouse strains that differ in their susceptibility to obesity-induced diabetes. Here we show the overexpression of micro-RNAs 132 and 212 enhances insulin secretion (IS) in response to glucose and other secretagogues including non-fuel stimuli. We determined that carnitine acyl-carnitine translocase (CACT, Slc25a20) is a direct target of these miRNAs.
    [Show full text]
  • Genome-Wide Screening Identifies Genes and Biological Processes
    Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 10-12-2018 Genome-Wide Screening Identifies Genes and Biological Processes Implicated in Chemoresistance and Oncogene-Induced Apoptosis Tengyu Ko Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Cancer Biology Commons, Cell Biology Commons, and the Genomics Commons Recommended Citation Ko, Tengyu, "Genome-Wide Screening Identifies Genes and Biological Processes Implicated in Chemoresistance and Oncogene- Induced Apoptosis" (2018). LSU Doctoral Dissertations. 4715. https://digitalcommons.lsu.edu/gradschool_dissertations/4715 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. GENOME-WIDE SCREENING IDENTIFIES GENES AND BIOLOGICAL PROCESSES IMPLICATED IN CHEMORESISTANCE AND ONCOGENE- INDUCED APOPTOSIS A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical and Veterinary Medical Sciences through the Department of Comparative Biomedical Sciences by Tengyu Ko B.S., University of California, Santa Barbara 2010 December 2018 ACKNOWLEDGEMENTS I would like to express my sincerest gratitude to my major supervisor Dr. Shisheng Li for giving me the opportunity to join his team and the freedom to pursue projects. I appreciate all of his thoughts and efforts. Truly, none of these findings would be possible without his supervisions, supports, insightful discussions, and patience.
    [Show full text]
  • Supplemental Figure 1. Protein-Protein Interaction Network with Increased Expression in Fteb During the Luteal Phase
    Supplemental Figure 1. Protein-protein interaction network with increased expression in FTEb during the luteal phase. Supplemental Figure 2. Protein-protein interaction network with decreased expression in FTEb during luteal phase. LEGENDS TO SUPPLEMENTAL FIGURES Supplemental Figure 1. Protein-protein interaction network with increased expression in FTEb during the luteal phase. Submission of probe sets differentially expressed in the FTEb specimens that clustered with SerCa as well as those specifically altered in FTEb luteal samples to the online I2D database revealed overlapping networks of proteins with increased expression in the four FTEb samples and/or FTEb luteal samples overall. Proteins are represented by nodes, and known and predicted first-degree interactions are represented by solid lines. Genes encoding proteins shown as large ovals highlighted in blue were exclusively found in the first comparison (Manuscript Figure 2), whereas those highlighted in red were only found in the second comparison (Manuscript Figure 3). Genes encoding proteins shown as large ovals highlighted in black were found in both comparisons. The color of each node indicates the ontology of the corresponding protein as determined by the Online Predicted Human Interaction Database (OPHID) link with the NAViGaTOR software. Supplemental Figure 2. Protein-protein interaction network with decreased expression in FTEb during the luteal phase. Submission of probe sets differentially expressed in the FTEb specimens that clustered with SerCa as well as those specifically altered in FTEb luteal samples to the online I2D database revealed overlapping networks of proteins with decreased expression in the four FTEb samples and/or FTEb luteal samples overall. Proteins are represented by nodes, and known and predicted first-degree interactions are represented by solid lines.
    [Show full text]
  • MAFB Determines Human Macrophage Anti-Inflammatory
    MAFB Determines Human Macrophage Anti-Inflammatory Polarization: Relevance for the Pathogenic Mechanisms Operating in Multicentric Carpotarsal Osteolysis This information is current as of October 4, 2021. Víctor D. Cuevas, Laura Anta, Rafael Samaniego, Emmanuel Orta-Zavalza, Juan Vladimir de la Rosa, Geneviève Baujat, Ángeles Domínguez-Soto, Paloma Sánchez-Mateos, María M. Escribese, Antonio Castrillo, Valérie Cormier-Daire, Miguel A. Vega and Ángel L. Corbí Downloaded from J Immunol 2017; 198:2070-2081; Prepublished online 16 January 2017; doi: 10.4049/jimmunol.1601667 http://www.jimmunol.org/content/198/5/2070 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2017/01/15/jimmunol.160166 Material 7.DCSupplemental References This article cites 69 articles, 22 of which you can access for free at: http://www.jimmunol.org/content/198/5/2070.full#ref-list-1 by guest on October 4, 2021 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • Conserved Human Effector Treg Cell Transcriptomic and Epigenetic Signature in Arthritic Joint Inflammation
    ARTICLE https://doi.org/10.1038/s41467-021-22975-7 OPEN Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation Gerdien Mijnheer1,6, Lisanne Lutter 1,6, Michal Mokry 1,2,3, Marlot van der Wal 1, Rianne Scholman1, Veerle Fleskens4, Aridaman Pandit 1, Weiyang Tao1, Mark Wekking3, Stephin Vervoort1,5, Ceri Roberts 4, Alessandra Petrelli1, Janneke G. C. Peeters 1, Marthe Knijff1, Sytze de Roock1, Sebastiaan Vastert1, ✉ Leonie S. Taams 4, Jorg van Loosdregt1,5,7 & Femke van Wijk 1,7 1234567890():,; Treg cells are critical regulators of immune homeostasis, and environment-driven Treg cell differentiation into effector (e)Treg cells is crucial for optimal functioning. However, human Treg cell programming in inflammation is unclear. Here, we combine transcriptional and epigenetic profiling to identify a human eTreg cell signature. Inflammation-derived functional Treg cells have a transcriptional profile characterized by upregulation of both a core Treg cell (FOXP3, CTLA4, TIGIT) and effector program (GITR, BLIMP-1, BATF). We identify a specific human eTreg cell signature that includes the vitamin D receptor (VDR) as a predicted regulator in eTreg cell differentiation. H3K27ac/H3K4me1 occupancy indicates an altered (super-)enhancer landscape, including enrichment of the VDR and BATF binding motifs. The Treg cell profile has striking overlap with tumor-infiltrating Treg cells. Our data demonstrate that human inflammation-derived Treg cells acquire a conserved and specific eTreg cell profile guided by epigenetic changes, and fine-tuned by environment-specific adaptations. 1 Center for Translational Immunology, Pediatric Immunology & Rheumatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
    [Show full text]
  • Massively Parallel Sequencing Identifies the Gene Megf8 with ENU-Induced Mutation Causing Heterotaxy
    Massively parallel sequencing identifies the gene Megf8 with ENU-induced mutation causing heterotaxy Zhen Zhanga, Deanne Alperta, Richard Francisa, Bishwanath Chatterjeea, Qing Yua, Terry Tanseya, Steven L. Sabola, Cheng Cuia, Yongli Baib, Maxim Koriabineb, Yuko Yoshinagab, Jan-Fang Chengc, Feng Chenc, Joel Martinc, Wendy Schackwitzc, Teresa M. Gunnd, Kenneth L. Kramera, Pieter J. De Jongb, Len A. Pennacchioc, and Cecilia W. Loa,1 aLaboratory of Developmental Biology, National Heart Lung and Blood Institute, Bethesda, MD 20892-1583; bBACPAC Resources Center, Children’s Hospital Oakland Research Institute, Oakland, CA 94609; cU.S. Department of Energy Joint Genome Institute, Walnut Creek, CA 94598; and dDepartment of Biomedical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY 14853 Communicated by Marshall Nirenberg, National Institutes of Health, Bethesda, MD, December 31, 2008 (received for review December 5, 2008) Forward genetic screens with ENU (N-ethyl-N-nitrosourea) mu- incomplete genome annotation. However, with rapid advances tagenesis can facilitate gene discovery, but mutation identification in a new generation of high throughput DNA sequencing is often difficult. We present the first study in which an ENU- technologies (4–6), rapid and low cost sequencing may greatly induced mutation was identified by massively parallel DNA se- facilitate mutation recovery from mutagenesis screens. These quencing. This mutation causes heterotaxy and complex congen- new sequencing technologies have already proven useful for ital heart defects and was mapped to a 2.2-Mb interval on mouse addressing a wide range of biological questions, from de novo chromosome 7. Massively parallel sequencing of the entire 2.2-Mb sequencing of microorganisms (7), cancer mutation discovery interval identified 2 single-base substitutions, one in an intergenic (8), gene expression profiling (9) to epigenetic regulation (10).
    [Show full text]
  • Chromatin-Remodeling Factor SMARCD2 Regulates Transcriptional Networks Controlling Differentiation of Neutrophil Granulocytes
    ARTICLES Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes Maximilian Witzel1,2, Daniel Petersheim1, Yanxin Fan1, Ehsan Bahrami1, Tomas Racek1, Meino Rohlfs1, Jacek Puchałka1,13, Christian Mertes2, Julien Gagneur2,3, Christoph Ziegenhain4, Wolfgang Enard4, Asbjørg Stray-Pedersen5, Peter D Arkwright6, Miguel R Abboud7, Vahid Pazhakh8, Graham J Lieschke8, Peter M Krawitz9, Maik Dahlhoff10, Marlon R Schneider10, Eckhard Wolf10, Hans-Peter Horny11, Heinrich Schmidt1, Alejandro A Schäffer12 & Christoph Klein1,2 We identify SMARCD2 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 2), also known as BAF60b (BRG1/Brahma-associated factor 60b), as a critical regulator of myeloid differentiation in humans, mice, and zebrafish. Studying patients from three unrelated pedigrees characterized by neutropenia, specific granule deficiency, myelodysplasia with excess of blast cells, and various developmental aberrations, we identified three homozygous loss-of-function mutations in SMARCD2. Using mice and zebrafish as model systems, we showed that SMARCD2 controls early steps in the differentiation of myeloid–erythroid progenitor cells. In vitro, SMARCD2 interacts with the transcription factor CEBPε and controls expression of neutrophil proteins stored in specific granules. Defective expression of SMARCD2 leads to transcriptional and chromatin changes in acute myeloid leukemia (AML) human promyelocytic cells. In summary, SMARCD2 is a key factor controlling myelopoiesis and is a potential tumor suppressor in leukemia. Differentiation of hematopoietic stem cells (HSCs) follows a hierarchi- The two paralogous proteins SMARCD1 (BAF60A) and SMARCD3 cal program of transcription factor–regulated events1–3. Early myeloid (BAF60C) control embryonic stem (ES) cell15 and heart muscle cell16 cell differentiation is dependent on PU.1 and CEBPα (CCAAT/ differentiation, respectively.
    [Show full text]